+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Allergy Immunotherapy Market Research Report by Type (SCIT and SLIT), Allergy Type, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 243 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4905050
UP TO OFF until Dec 31st 2022
The Global Allergy Immunotherapy Market size was estimated at USD 3,815.19 million in 2021, USD 4,132.61 million in 2022, and is projected to grow at a CAGR 8.49% to reach USD 6,223.33 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Allergy Immunotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across SCIT and SLIT.
  • Based on Allergy Type, the market was studied across Allergic Rhinitis, Asthma, Food Allergy, and Venom Allergy.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy and Drug Stores.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Allergy Immunotherapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Immunotherapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Immunotherapy Market, including Adamis Pharmaceuticals Corporation, Aimmune Therapeutics, Inc, ALK, ALK-Abelló A/S, Allergy Therapeutics, Allovate, LLC, Anergis SA, ASIT Biotech SA, Biomay AG, Circassia, DBV Technologies SA, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, Inimmune Corporation, Jubilant Life Sciences Ltd, LETIPharma GmBH, Merck KGaA, Mylan N.V., Sandoz, Stallergenes Greer PLC, and Torii Pharmaceutical Co. Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Allergy Immunotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Immunotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Immunotherapy Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Immunotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Immunotherapy Market?
6. What is the market share of the leading vendors in the Global Allergy Immunotherapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Allergy Immunotherapy Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in demand due to increasing prevalence of allergies
5.1.1.2. Surge in demand due to shift in lifestyle and environmental factors
5.1.2. Restraints
5.1.2.1. Higher upfront cost of treatment
5.1.2.2. Risk of side effects such redness, swelling, and tenderness
5.1.3. Opportunities
5.1.3.1. Increasing healthcare expenditure in the developing economies
5.1.3.2. Rising awareness among people about advanced immunotherapies
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Cumulative Impact of COVID-19
6. Allergy Immunotherapy Market, by Type
6.1. Introduction
6.2. SCIT
6.3. SLIT
7. Allergy Immunotherapy Market, by Allergy Type
7.1. Introduction
7.2. Allergic Rhinitis
7.3. Asthma
7.4. Food Allergy
7.5. Venom Allergy
8. Allergy Immunotherapy Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy and Drug Stores
9. Americas Allergy Immunotherapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Allergy Immunotherapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Allergy Immunotherapy Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Adamis Pharmaceuticals Corporation
13.2. Aimmune Therapeutics, Inc
13.3. ALK
13.4. ALK-Abelló A/S
13.5. Allergy Therapeutics
13.6. Allovate, LLC
13.7. Anergis SA
13.8. ASIT Biotech SA
13.9. Biomay AG
13.10. Circassia
13.11. DBV Technologies SA
13.12. DESENTUM OY
13.13. HAL Allergy B.V.
13.14. HollisterStier Allergy
13.15. Inimmune Corporation
13.16. Jubilant Life Sciences Ltd
13.17. LETIPharma GmBH
13.18. Merck KGaA
13.19. Mylan N.V.
13.20. Sandoz
13.21. Stallergenes Greer PLC
13.22. Torii Pharmaceutical Co. Ltd.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET DYNAMICS
FIGURE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2027
FIGURE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 29. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 37. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 39. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 45. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2027
FIGURE 47. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 49. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 51. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 66. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 78. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 58. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 60. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 61. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 62. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 64. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 65. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 66. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 68. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 69. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 70. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 72. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 73. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 77. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 84. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 86. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 87. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 88. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 90. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 91. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 92. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 94. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 95. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 96. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 98. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 99. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 100. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 102. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 103. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 104. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 106. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 107. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 108. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 110. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 111. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 112. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 114. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 115. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 116. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 118. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 119. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 120. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 122. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 123. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 124. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 126. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 127. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 133. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 135. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 136. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 137. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 139. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 140. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 141. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 143. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 144. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 145. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 147. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 148. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 149. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 151. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 152. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 153. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 155. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 156. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 157. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 159. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 160. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 161. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 162. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 163. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 164. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 165. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 167. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 168. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 173. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 175. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2019-2027 (USD MILLION)
TABLE 176. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 177. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 178. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 179. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 180. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RANKING
TABLE 181. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 182. GLOBAL ALLERGY IMMUNOTHERAPY MARKET MERGER & ACQUISITION
TABLE 183. GLOBAL ALLERGY IMMUNOTHERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 184. GLOBAL ALLERGY IMMUNOTHERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 185. GLOBAL ALLERGY IMMUNOTHERAPY MARKET INVESTMENT & FUNDING
TABLE 186. GLOBAL ALLERGY IMMUNOTHERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 187. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: LICENSE & PRICING

Companies Mentioned

  • Adamis Pharmaceuticals Corporation
  • Aimmune Therapeutics, Inc
  • ALK
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Allovate, LLC
  • Anergis SA
  • ASIT Biotech SA
  • Biomay AG
  • Circassia
  • DBV Technologies SA
  • DESENTUM OY
  • HAL Allergy B.V.
  • HollisterStier Allergy
  • Inimmune Corporation
  • Jubilant Life Sciences Ltd
  • LETIPharma GmBH
  • Merck KGaA
  • Mylan N.V.
  • Sandoz
  • Stallergenes Greer PLC
  • Torii Pharmaceutical Co. Ltd.

Methodology

Loading
LOADING...